Mendoza Hector, Jash Eshna, Davis Michael B, Haines Rebecca A, Van Diepenbos Sarah, Csankovszki Györgyi
bioRxiv. 2024 Sep 27:2024.09.25.615038. doi: 10.1101/2024.09.25.615038.
RNA interference is a conserved silencing mechanism that depends on the generation of small RNA molecules that disrupt synthesis of their corresponding transcripts. Nuclear RNA interference is a unique process that triggers regulation through epigenetic alterations to the genome. This pathway has been extensively characterized in and involves the nuclear recruitment of H3K9 histone methyltransferases by the Argonautes HRDE-1 and NRDE-3. The coordinate regulation of genetic targets by H3K9 methylation and the nuclear Argonautes is highly complex and has been mainly described based on the small RNA populations that are involved. Recent studies have also linked the nuclear RNAi pathway to the compaction of the hermaphrodite X chromosomes during dosage compensation, a mechanism that balances genetic differences between the biological sexes by repressing X chromosomes in hermaphrodites. This chromosome-wide process provides an excellent opportunity to further investigate the relationship between H3K9 methylation and the nuclear Argonautes from the perspective of the transcriptome. Our work suggests that the nuclear RNAi and the H3K9 methylation pathways each contribute to the condensation of the X chromosomes during dosage compensation but the consequences on their transcriptional output are minimal. Instead, nuclear RNAi mutants exhibit global transcriptional differences, in which HRDE-1 and NRDE-3 affect expression of their native targets through different modes of regulation and different relationships to H3K9 methylation.
This study examines the transcriptional consequences during the disruption of the nuclear RNAi silencing mechanism in . Through microscopy and bioinformatic work, we demonstrate that although nuclear RNAi mutants exhibit significantly decondensed X chromosomes, chromosome-wide transcriptional de-repression is not detectable. Downstream analyses further explore the global influence of the nuclear RNAi pathway, indicating that the nuclear Argonautes HRDE-1 and NRDE-3 function through two distinct mechanisms.
RNA干扰是一种保守的沉默机制,它依赖于小RNA分子的产生,这些小RNA分子会破坏其相应转录本的合成。核RNA干扰是一个独特的过程,通过对基因组的表观遗传改变来触发调控。该途径已在[具体生物]中得到广泛表征,涉及AGO蛋白HRDE-1和NRDE-3将H3K9组蛋白甲基转移酶招募到细胞核。H3K9甲基化和核AGO蛋白对基因靶点的协同调控非常复杂,主要是基于所涉及的小RNA群体进行描述的。最近的研究还将核RNAi途径与雌雄同体剂量补偿过程中X染色体的压缩联系起来,剂量补偿是一种通过抑制雌雄同体中的X染色体来平衡两性之间遗传差异的机制。这个全染色体范围的过程为从转录组的角度进一步研究H3K9甲基化与核AGO蛋白之间的关系提供了绝佳机会。我们的工作表明,核RNAi和H3K9甲基化途径在剂量补偿过程中都对X染色体的浓缩有贡献,但对其转录输出的影响很小。相反,核RNAi突变体表现出全局转录差异,其中HRDE-1和NRDE-3通过不同的调控模式和与H3K9甲基化的不同关系影响其天然靶点的表达。
本研究考察了[具体生物]中核RNAi沉默机制被破坏时的转录后果。通过显微镜观察和生物信息学工作,我们证明,尽管核RNAi突变体表现出明显解压缩的X染色体,但全染色体范围的转录去抑制是不可检测的。下游分析进一步探索了核RNAi途径的全局影响,表明核AGO蛋白HRDE-1和NRDE-3通过两种不同的机制发挥作用。